The article below may contain offensive and/or incorrect content.
A small molecular compound has been discovered that can activate the Wnt pathway in non-Wnt subtypes of medulloblastoma brain cancer, making tumors more responsive to therapies.Article Correctness Is Author's Responsibility: Making Brain Cancers in Children Respond Better to Treatment
A small molecular compound has been discovered that can activate the Wnt pathway in non-Wnt subtypes of medulloblastoma brain cancer, making tumors more responsive to therapies.
